S. Rosén

发表

Activated protein C resistance--a major risk factor for thrombosis.

A. Sturk, A. Sturk, S. Rosén, 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Chromogenic methods in coagulation diagnostics

S. Rosén, 2005, Hämostaseologie.

Evaluation of a bioimmuno assay for t-PA activity and its relation to PAI-1 activity and antigen levels

C. Kluft, P. Meijer, L. Tengborn, 1998 .

Activity of Transgene-Produced B-Domain Deleted Factor VIII in Human Plasma Following AAV5 Gene Therapy.

K. Pasi, S. Rangarajan, G. Pierce, 2020, Blood.

Evaluation of a modified APTT-based method for determination of APC resistance in plasma from patients on heparin or oral anticoagulant therapy.

U. Zetterberg, S. Rosén, C. Hall, 1998, Thrombosis research.

Resistance to activated protein C, the FV : Q506 allele, and venous thrombosis

B. Dahlbäck, A. Hillarp, B. Zöller, 1996, Annals of Hematology.

Response to activated protein C upon storage of whole blood and plasma.

G. Freyburger, S. Rosén, M. Andras, 1999, Thrombosis research.

Multicenter Evaluation of a Kit for Activated Protein C Resistance on Various Coagulation Instruments Using Plasmas from Healthy Individuals

B. Dahlbäck, S. Rosén, K. Johansson, 1994, Thrombosis and Haemostasis.

Bioimmunoassay for tissue-type plasminogen activator (t-PA) in human plasma: Evaluation of blood sampling and handling procedures and comparison with other t-PA activity methods

C. Kluft, P. Meijer, R. Boon, 1992 .

A New Kit for the Determination of Tissue Plasminogen Activator and its Inhibitor in Blood

S. Rosén, P. Friberger, K. Nilsson, 1987 .

A simple and accurate microplate assay for the determination of factor VIII activity.

S. Rosén, U. Oswaldsson, G. Carlebjörk, 1987, Thrombosis research.

Assay of factor VIII:C with a chromogenic substrate.

S. Rosén, 2009, Scandinavian journal of haematology. Supplementum.

APC Resistance and other Haemostatic Variables during Pregnancy and Puerperium

L. Tengborn, M. Hellgren, U. Kjellberg, 1999, Thrombosis and Haemostasis.

Chromogenic determination of factor VIII activity in plasma and factor VIII concentrates By

S. Rosén, M. C. Casoni, 2006 .

Tissue-type plasminogen activator (t-PA) activity

C. Kluft, P. Meijer, E. Ersdal, 1999 .

The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.

P. Sandset, U. Abildgaard, O. Odegaard, 1988, Folia haematologica.

Discrepancies between the one‐stage clotting assay and the chromogenic assay in haemophilia B

J. Astermark, R. Ljung, K. Strandberg, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Overestimation of N‐glycoPEGylated factor IX activity in a one‐stage factor IX clotting assay owing to silica‐mediated premature conversion to activated factor IX

E. Persson, M. Ezban, S. Rosén, 2016, Journal of thrombosis and haemostasis : JTH.

Qualification of a select one‐stage activated partial thromboplastin time‐based clotting assay and two chromogenic assays for the post‐administration monitoring of nonacog beta pegol

J. Amiral, R. Bohra, S. Kitchen, 2017, Journal of thrombosis and haemostasis : JTH.

FIX potency of rFIX‐Albumin fusion protein is underestimated by one‐stage methods using silica‐based APTT reagents

S. Rosén, Pia Bryngelhed, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Haemophilia A and von Willebrand’s disease

B. Verbruggen, A. Goodeve, S. Rosén, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical Application of a Chromogenic Substrate Method for Determination of Factor VIII Activity

M. Blombäck, M. Andersson, I. Nilsson, 1985, Thrombosis and Haemostasis.

Efl ' ect of Divalent Cations on the Ingestion of Lipopolysaccharide Particles by Guinea Pig Granulocytes

T. Stossel, C. Alper, S. Rosén, 2003 .

Criteria for specific measurement of plasminogen (enzymatic; procedure) in human plasma

J. Hoffmann, M. Nesheim, N. Booth, 2000, EJIFCC.

A new variant of interaction between phospholipid antibodies and the protein C system

M. Blombäck, M. Bokarewa, N. Egberg, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

New aspects of blood collection and handling procedures for the assessment of t-PA and PAI-1 variables after the introduction of acid blood collection

C. Kluft, P. Meijer, S. Rosén, 1994 .

Blood sampling and determination of tissue plasminogen activator activity with COA-SET® t-PA

J. Chmielewska, B. Brandt, S. Rosén, 1990 .

Determination of factor VIII activity in plasma and concentrates: comparison between methods.

S. Rosén, M. C. Casoni, 2002, American clinical laboratory.

New Tools to Study Contact Activation

S. Rosén, 2016, Front. Med..

Haemophilia A and von Willebrand’s disease

S. Rosén, A. Goodeve, Bert Verbruggen, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.